. However, warfarin anticoagulation has been shown to be less effective than antiplatelet therapy for secondary prevention of neurologic events in
patients with carotid atherosclerosis who do not have a
history of atrial fibrillation and is not indicated in patients
with symptoms of cerebral ischemia.150,151 The WarfarinAspirin Reduced Cardiac Ejection Fraction Study trial is
currently investigating the potential advantage in preventing cardioembolic stroke